These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4429976)

  • 1. [Haemodynamic effect of short-term adrenergic block with prindolol at rest and during strain in hypertonic subjects (stage II)].
    Ressl J; Chrástek J; Jandová R; Nhon TQ
    Cas Lek Cesk; 1974 Oct; 113(43):1317-21. PubMed ID: 4429976
    [No Abstract]   [Full Text] [Related]  

  • 2. [A controlled clinical therapeutic trial of prindolol in patients with arterial hypertension (author's transl)].
    Marinković M; Winter-Fudurić ; Kuzmanić D
    Lijec Vjesn; 1976 Apr; 98(4):172-6. PubMed ID: 787710
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pressor reaction of hypertonic subjects to physical exercise of submaximal intensity under the influence of beta-adrenergic block (Pindolol) (author's transl)].
    Chrástek J; Boudová L; Kavánková M; Benes K; Krízek V; Matousek O
    Sb Lek; 1973 Oct; 75(10):301-11. PubMed ID: 4759769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of essential hypertension with pindolol].
    Kocemba J; Kawecka-Jaszcz K; Sniezek M; Starzycka M; Augustyński W
    Kardiol Pol; 1978; 21(3):201-8. PubMed ID: 691928
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of treatment with pindolol (Visken) on hemodynamics in patients with primary hypertension].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1986; 29(4):285-91. PubMed ID: 3537436
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of beta-adrenergic block with pindolol on the haemodynamics, oxygen consumption and pH of blood of the hypertensive patient during submaximum effort (author's transl)].
    Chrástek J; Kavánková M; Boudová L; Zenísek A; Matousek O
    Cas Lek Cesk; 1973 Sep; 112(39):1209-12. PubMed ID: 4744776
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemodynamic effects of pindolol in hypertensive patients.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand Suppl; 1977; 606():55-62. PubMed ID: 268933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of essential hypertension with prindolol].
    Kuska J; Sledzinski Z; Kokot F
    Wiad Lek; 1977 Apr; 30(7):505-10. PubMed ID: 855327
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
    v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
    J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adrenergic beta receptor blockaders with intrinsic sympathomimetic activity in the treatment of arterial hypertension].
    Pyda M; Grajek S
    Kardiol Pol; 1988; 31(4):261-70. PubMed ID: 2906104
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
    Reffo GC; Pitzorno G; Perin S; Forattini C
    Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prindolol in the therapy of arterial hypertension].
    Cocco G; Jerie P
    Boll Soc Ital Cardiol; 1975; 20(11):1449-55. PubMed ID: 1234443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peripheral vascular effects of metoprolol, pindolol and propranolol in hypertensive patients].
    Joyal F; Bourque M; Kuchel O; Larochelle P
    J Pharmacol; 1983; 14 Suppl 2():107-15. PubMed ID: 6138462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
    Erkinaro T; Kavasmaa T; Ylikauma L; Mäkikallio K; Haapsamo M; Acharya G; Ohtonen P; Alahuhta S; Räsänen J
    Reprod Sci; 2009 Aug; 16(8):749-57. PubMed ID: 19380903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pindolol on blood parathyroid hormone concentration.
    Shasha SM; Ben Aryeh H; Shiller M; Bernheim J
    Isr J Med Sci; 1981 Dec; 17(12):1189-90. PubMed ID: 7327921
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
    Lil'in ET; Vavilova TA; Mar'in MI
    Klin Med (Mosk); 1983 Sep; 61(9):85-9. PubMed ID: 6139506
    [No Abstract]   [Full Text] [Related]  

  • 20. [Centra, peripheral, and volumetric hemodynamic changes in the treatment of essential hypertension with calcium antagonists and beta blockaders].
    Mattioli G; Ricci S; Teglio V
    Minerva Cardioangiol; 1980 May; 28(5):295-302. PubMed ID: 6111047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.